Crestovo's Merger

Crestovo raised a round of funding on October 23, 2017. Investors include Finch Therapeutics Group.

Crestovo leverages its Full-Spectrum Microbiota platform to develop therapeutics that harness the human gut microbiome to restore diversity of healthy microorganisms.…

Articles about Crestovo's Merger: